Search Results - "Hunzelmann N"

Rituximab in refractory autoimmune bullous diseases.

Authors: Schmidt, E. Hunzelmann, N. Zillikens, D. et al.

Source: Clinical & Experimental Dermatology. Jul2006, Vol. 31 Issue 4, p503-508. 6p.

Detection and characterization of plasma cells in peripheral blood: correlation of IgE⁺ plasma cell frequency with IgE serum titre.

Authors: HORST, A. HUNZELMANN, N. ARCE, S. et al.

Source: Clinical & Experimental Immunology. Dec2002, Vol. 130 Issue 3, p370-378. 9p.

The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.

Authors: Hunzelmann, N. Riemekasten, G. Becker, M.O. et al.

Source: British Journal of Dermatology. Jun2016, Vol. 174 Issue 6, p1384-1387. 4p.

Increased deposition of fibulin-2 in solar elastosis and its colocalization with elastic fibres.

Authors: Hunzelmann, N. Nischt, R. Brenneisen, P. et al.

Source: British Journal of Dermatology. Aug2001, Vol. 145 Issue 2, p217-222. 6p. 6 Black and White Photographs, 1 Diagram.

Caffeine hypersensitivity.

Authors: Hinrichs, R. Hunzelmann, N. Ritzkowsky, A. et al.

Source: Allergy. Sep2002, Vol. 57 Issue 9, p859-860. 3p.

Recurrence rates in localized scleroderma (morphoea).

Authors: Kreuter, A. Hunzelmann, N.

Source: British Journal of Dermatology. Mar2015, Vol. 172 Issue 3, p562-563. 2p.

ALLERGY Net Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization.

Authors: Sacher, C. Hunzelmann, N.

Source: Allergy. Dec2003, Vol. 58 Issue 12, p1318-1319. 2p.

Immediate‐type reactions to cisatracurium.

Authors: Hunzelmann, N. Kopner, R. Hani, N. et al.

Source: Allergy. Nov99, Vol. 54 Issue 11, p1227-1228. 2p. 1 Chart.

Applicability of reference values for the determination of serum S100 protein as a marker of malignant melanoma in children.

Authors: Hunzelmann, N Kurschat, P Hani, N et al.

Source: British Journal of Dermatology. Mar2002, Vol. 146 Issue 3, p536-536. 1p. 2 Black and White Photographs, 1 Graph.

European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.

Authors: Knobler, R. Moinzadeh, P. Hunzelmann, N. et al.

Source: Journal of the European Academy of Dermatology & Venereology. Sep2017, Vol. 31 Issue 9, p1401-1424. 24p.

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.

Authors: Knobler, R. Geroldinger‐Simić, M. Kreuter, A. et al.

Source: Journal of the European Academy of Dermatology & Venereology. Jul2024, Vol. 38 Issue 7, p1251-1280. 30p.

IgE-mediated anaphylactic reaction to purified and recombinant factor VIII in a patient with severe haemophilia A.

Authors: KADAR, J. G. SCHUSTER, J. HUNZELMANN, N.

Source: Haemophilia. Jan2007, Vol. 13 Issue 1, p104-105. 2p. 1 Diagram.

Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.

Authors: Pfaar, O. Hohlfeld, J. M. Al‐Kadah, B. et al.

Source: Clinical & Experimental Allergy. Nov2017, Vol. 47 Issue 11, p1445-1455. 11p.

Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting.

Authors: Schattenkirchner, S. Eming, S. Hunzelmann, N. et al.

Source: British Journal of Dermatology. Nov1999, Vol. 141 Issue 5, p932-933. 4p.

Elevated levels of tryptase in children with nummular eczema.

Authors: Lange, L. Rietschel, E. Hunzelmann, N. et al.

Source: Allergy. Jul2008, Vol. 63 Issue 7, p947-949. 3p. 1 Graph.

Discrete papular mucinosis—a rare subtype of lichen myxoedematosus.

Authors: Poswig, A. Hinrichs, R. Megahed, M. et al.

Source: Clinical & Experimental Dermatology. Jun2000, Vol. 25 Issue 4, p289-292. 4p.

Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis.

Authors: McKinney, C Broen, J C A Vonk, M C et al.

Source: Genes & Immunity. Sep2012, Vol. 13 Issue 6, p458-460. 3p. 1 Chart.

Treatment of pruritus by capsaicin in a patient with pityriasis rubra pilaris receiving RE-PUVA therapy.

Authors: Neess, C. M. Hinrichs, R. Dissemond, J. et al.

Source: Clinical & Experimental Dermatology. May2000, Vol. 25 Issue 3, p209-211. 3p. 2 Black and White Photographs.

European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.

Authors: Knobler, R. Moinzadeh, P. Hunzelmann, N. et al.

Source: Journal of the European Academy of Dermatology & Venereology. Oct2017, Vol. 31 Issue 10, p1581-1594. 0p.

Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab).

Authors: Herrmann, G. Engert, A. Hunzelmann, N.

Source: British Journal of Dermatology. Mar2003, Vol. 148 Issue 3, p602-603. 2p.